{"id":46938,"date":"2026-01-18T11:35:23","date_gmt":"2026-01-18T11:35:23","guid":{"rendered":"https:\/\/quickassetsmarket.com\/index.php\/2026\/01\/18\/why-analysts-are-not-impressed-with-trumps-great-healthcare-plan\/"},"modified":"2026-01-18T11:35:23","modified_gmt":"2026-01-18T11:35:23","slug":"why-analysts-are-not-impressed-with-trumps-great-healthcare-plan","status":"publish","type":"post","link":"https:\/\/quickassetsmarket.com\/index.php\/2026\/01\/18\/why-analysts-are-not-impressed-with-trumps-great-healthcare-plan\/","title":{"rendered":"Why analysts are not impressed with Trump\u2019s \u2018Great Healthcare Plan\u2019"},"content":{"rendered":"<div><\/div>\n<p>The Trump administration on Thursday unveiled what it called the \u201cGreat Healthcare Plan,\u201d a broad framework aimed at addressing healthcare affordability, drug prices, and insurance transparency. <\/p>\n<p>While the White House described the plan as a decisive step toward reform, analysts and healthcare policy experts largely characterized it as lacking detail, politically constrained, and unlikely to deliver meaningful near-term relief.<\/p>\n<p>The framework arrives amid heightened concern over rising healthcare costs, particularly as enhanced Affordable Care Act (ACA) subsidies expired last year, driving up premiums and deductibles for millions of Americans. <\/p>\n<p>Thursday was also the final day of open enrollment for Obamacare plans, underscoring the timing and political sensitivity of the announcement.<\/p>\n<h2 class=\"wp-block-heading\">A broad framework with limited specifics<\/h2>\n<p>According to the White House, the Great Healthcare Plan rests on four pillars: drug price reforms, health insurance reforms, price transparency for healthcare costs, and fraud protections and safeguards. <\/p>\n<p>Elements highlighted by the administration include funding for health savings accounts, transparency requirements for insurers and providers to publicly post prices, and a call for Congress to codify pricing deals President Trump has made with pharmaceutical companies.<\/p>\n<p>Dr. Mehmet Oz, Trump&#8217;s administrator for the Centers for Medicare and Medicaid Services, said during a call with the reporters that \u201cInstead just papering over the problems, we have gotten into this \u2018Great Healthcare Plan\u2019 a framework that we believe will help Congress create legislation that will address the challenges&#8221;.<\/p>\n<p>President Trump echoed that urgency in the call accompanying the plan\u2019s release, saying he is \u201ccalling on Congress to pass this framework into law without delay,\u201d adding that lawmakers \u201chave to do it right now so that we can get immediate relief to the American people.\u201d<\/p>\n<p>However, when pressed for policy specifics, administration officials described the proposal as a \u201cbroad framework,\u201d offering few details on implementation or legislative pathways.<\/p>\n<h2 class=\"wp-block-heading\">Analysts see familiar ideas and political hurdles<\/h2>\n<p>Market analysts and policy experts were notably skeptical. <\/p>\n<p>Spencer Perlman, director of healthcare research at Veda Partners, said in a MarketWatch report that the plan appears designed to signal action rather than deliver results. <\/p>\n<p>\u201cWe think it is intended to demonstrate that the White House is doing \u2018something\u2019 about affordability and healthcare prices, but we believe the policies either stand little chance of being enacted by the current Congress or will have a minimal impact if enacted,\u201d he wrote in a note.<\/p>\n<p>Others echoed that view. <\/p>\n<p>\u201cTheir ideas are nothing new, nothing unexpected, pretty challenging to implement,\u201d said Kim Monk, a healthcare policy analyst at Capital Alpha Partners. <\/p>\n<p>\u201cI\u2019m not seeing anything earth-changing.\u201d Raymond James analyst Chris Meekins described the proposal as \u201ca retread of previously advocated-for positions,\u201d adding that \u201cthere is no legislative path forward for much of it, in our view.\u201d<\/p>\n<p>Healthcare policy researchers also warned that the plan does not address the most immediate pressure point: rising ACA premiums. <\/p>\n<p>Cynthia Cox, a senior vice president at KFF, said in an npr report that the framework \u201clooks much more like a compilation of Republican ideas\u201d and \u201cdoesn\u2019t appear to address the rising premium payments that we\u2019re seeing.\u201d<\/p>\n<h2 class=\"wp-block-heading\">ACA implications<\/h2>\n<p>The plan\u2019s silence on extending ACA enhanced subsidies has amplified concerns that millions could face higher costs or lose coverage altogether. <\/p>\n<p>Edwin Park, a research professor at Georgetown University\u2019s McCourt School of Public Policy, said in a Guardian report that the framework \u201cclearly opposes extension of the expiring ACA marketplace subsidies,\u201d warning that \u201croughly 4 million people will end up uninsured and many millions more will see their marketplace premiums double or increase by even more.\u201d<\/p>\n<p>Bipartisan talks in the Senate to revive the subsidies are continuing, with some lawmakers expressing cautious optimism. <\/p>\n<p>Still, experts warn that without concrete legislative action, the Great Healthcare Plan may struggle to move beyond rhetoric.<\/p>\n<\/p>\n<p>The post <a href=\"https:\/\/invezz.com\/news\/2026\/01\/17\/why-analysts-are-not-impressed-with-trumps-great-healthcare-plan\/\">Why analysts are not impressed with Trump&#8217;s \u2018Great Healthcare Plan&#8217;<\/a> appeared first on <a href=\"https:\/\/invezz.com\/\">Invezz<\/a><\/p>\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The Trump administration on Thursday unveiled what it called the \u201cGreat Healthcare Plan,\u201d a broad framework aimed at addressing healthcare affordability, drug prices, and insurance transparency. While the White House described the plan as a decisive step toward reform, analysts and healthcare policy experts largely characterized it as lacking detail, politically constrained, and unlikely to <\/p>\n","protected":false},"author":1,"featured_media":46939,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":{"0":"post-46938","1":"post","2":"type-post","3":"status-publish","4":"format-standard","5":"has-post-thumbnail","7":"category-investing"},"_links":{"self":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/46938","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/comments?post=46938"}],"version-history":[{"count":0,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/posts\/46938\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media\/46939"}],"wp:attachment":[{"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/media?parent=46938"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/categories?post=46938"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/quickassetsmarket.com\/index.php\/wp-json\/wp\/v2\/tags?post=46938"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}